Concepedia

Publication | Closed Access

Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)

DOI

94

Citations

0

References

2019

Year

Matthew R. Smith, Shahneen Sandhu, William Kevin Kelly, Howard I. Scher, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, K.N. Chi, Fred Saad,
Annals of Oncology

No additional data available for this publication yet. Check back later!